Atai Life Sciences Share Holder Equity 2020-2025 | ATAI
Atai Life Sciences share holder equity from 2020 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
Atai Life Sciences Annual Share Holder Equity
(Millions of US $) |
| 2024 |
$117 |
| 2023 |
$244 |
| 2022 |
$266 |
| 2021 |
$386 |
| 2020 |
$95 |
| 2019 |
$60 |
Atai Life Sciences Quarterly Share Holder Equity
(Millions of US $) |
| 2025-03-31 |
$152 |
| 2024-12-31 |
$117 |
| 2024-09-30 |
$146 |
| 2024-06-30 |
$169 |
| 2024-03-31 |
$223 |
| 2023-12-31 |
$244 |
| 2023-09-30 |
$269 |
| 2023-06-30 |
$216 |
| 2023-03-31 |
$241 |
| 2022-12-31 |
$266 |
| 2022-09-30 |
$296 |
| 2022-06-30 |
$320 |
| 2022-03-31 |
$354 |
| 2021-12-31 |
$386 |
| 2021-09-30 |
$463 |
| 2021-06-30 |
$485 |
| 2021-03-31 |
$120 |
| 2020-12-31 |
$95 |
| 2020-09-30 |
$0 |
| 2020-06-30 |
$0 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
$60 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.541B |
$0.000B |
|
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|
